Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

UFS confers honorary doctorate on one of the world’s foremost academics
2012-11-26

Prof. Martha Nussbaum
Photo: Supplied
26 November 2012

The University of the Free State (UFS) will confer three honorary doctorates at the Summer graduation ceremony on 6 December 2012. One of the world’s foremost philosophers is among those to be honoured. Prof. Martha Nussbaum, described by The New York Times as “one of the most prominent female philosophers in America”, will be honoured with a D.Litt. degree in the Faculty of Humanities. Judge F.D.J. Brand, a former Constitutional Court judge, and Prof. Otto Walter Prozesky, one of the country’s foremost medical researchers, will also receive honorary doctorates.

Prof. Nussbaum, who has honorary doctorates from 40 colleges and universities in America, Canada, Asia and Europe, is recognised for her intellectual and public contribution to human development. She is the Ernst Freund Distinguished Service Professor of Law and Ethics at the University of Chicago and an active member of the American Philosophy Association. Prof. Nussbaum is well-known and respected as a public intellectual and is considered to be one of the most prominent philosophers in the world.

Prof. Prozesky is to be honoured for the important role that he played in the field of medical research, especially as the President of the Medical Research Council and as researcher/educator in the field of virology and HIV/Aids. He is to receive an honorary degree in Medicine in the Faculty of Health Sciences.

Judge Brand, Extraordinary Professor in Private Law in the Faculty of Law at the UFS, is to receive a Doctor Legum degree in recognition of his considerable contribution to the legal science. More than 120 of his judgments are reported in South African legal reports. A review of recent South African legal journals (over the past five years) shows that reference is made to his judgments in at least 30 articles and case discussions.

The Summer graduation ceremony will be held in the Callie Human Centre on the Bloemfontein Campus and will take place in two ceremonies. At 10:15, master’s degrees and doctorates will be awarded, and at 15:15 qualifications will be awarded in a combined graduation ceremony of the Faculty of Health Sciences and the School of Open Learning.

  • Prof. Martha Nussbaum will lead a conversation with members of the public and the campus community on 7 December 2012. On 8 December 2012, she is the main speaker at the UFS’s conference on “Engaging the Other: Empathy and Breaking Transgenerational Cycles of Repetition” on the Bloemfontein Campus.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept